
A Nature study that could have provided a “potential therapeutic target for osteoporosis and bone metastases of cancer” has been retracted.
Since being published in 2014 by researchers at UT Southwestern, MD Anderson and elsewhere, “miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2” has been cited more than 200 times, according to Clarivate Analytics’ Web of Science.
A year ago — on May 24, 2019 — Nature published a correction to the paper:
Continue reading Nature retracts study touted as step toward treatments for bone diseases